BioLineRx (TASE: BLRX)

Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI).

Get a Demo and See the Full Profile

Get a demo today to see profiles of BioLineRx (TASE: BLRX) plus 6037 other startups.

Learn More About BioLineRx (TASE: BLRX)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More